Works matching IS 26882663 AND DT 2025 AND VI 6 AND IP 2


Results: 37
    1

    Once‐weekly glucagon‐like peptide receptor agonist polyethylene glycol loxenatide protects against major adverse cardiovascular events in patients with type 2 diabetes: a multicenter ambispective cohort study (FLYING trial).

    Published in:
    MedComm, 2025, v. 6, n. 2, p. 1, doi. 10.1002/mco2.70094
    By:
    • Li, Jilin;
    • Tian, Yu;
    • Li, Liping;
    • Zhao, Yanyan;
    • Yang, Shuhui;
    • Xu, Wencan;
    • Zhu, Dan;
    • Ye, Junjun;
    • Chen, Jingxian;
    • Liu, Weiting;
    • Xue, Haibo;
    • Wu, Wei;
    • Deng, Feiying;
    • Duan, Yale;
    • Hu, Zhizhen;
    • Xie, Bin;
    • Chen, Zhe‐Sheng;
    • Hou, Kaijian
    Publication type:
    Article
    2

    Issue Information.

    Published in:
    MedComm, 2025, v. 6, n. 2, p. 1, doi. 10.1002/mco2.70093
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Circular RNAs in cancer.

    Published in:
    MedComm, 2025, v. 6, n. 2, p. 1, doi. 10.1002/mco2.70079
    By:
    • Guo, Yang;
    • Huang, Qiang;
    • Heng, Yu;
    • Zhou, Yujuan;
    • Chen, Hui;
    • Xu, Chengzhi;
    • Wu, Chunping;
    • Tao, Lei;
    • Zhou, Liang
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37